Incannex Healthcare (IXHL) Total Current Liabilities (2020 - 2026)
Incannex Healthcare (IXHL) posted Total Current Liabilities of $1.9 million for Q1 2026, up 24.56% sequentially from $1.5 million in Q4 2025, and down 73.85% YoY from $7.4 million in Q1 2025.
Incannex Healthcare (IXHL) Total Current Liabilities (2020 - 2026) Analysis & Trends
Incannex Healthcare has reported Total Current Liabilities for 7 years, with the latest figure at $1.9 million in Q1 2026.
- Quarterly Total Current Liabilities fell 73.85% year-over-year to $1.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.9 million (down 73.85% YoY) and the FY2025 annual result came in at $7.0 million, up 24.27% from the prior year.
- Total Current Liabilities advanced to $1.9 million in Q1 2026 per IXHL's latest filing, from $1.5 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $9.2 million in Q3 2024 and troughed at $1.1 million in Q4 2022.
- A 5-year average of $4.0 million and a median of $2.9 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2023 and 2025: Total Current Liabilities surged 184.57% in 2023, then plunged 82.15% in 2025.
- Over 5 years, Total Current Liabilities stood at $1.1 million in 2022, then soared by 184.57% to $3.2 million in 2023, then surged by 83.3% to $5.8 million in 2024, then tumbled by 73.51% to $1.5 million in 2025, then gained by 24.56% to $1.9 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $1.9 million, $1.5 million, and $1.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | -8.38 Bn |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | 15.65 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | 2.06 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 17.34 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 607.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 6.35 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 874.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 1.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | 1.79 Bn |
| 10 | Incannex Healthcare | 41.74 Mn | 41.74 Mn | - | 1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.93 Mn |
| Dec 31, 2025 | 1.55 Mn |
| Sep 30, 2025 | 1.65 Mn |
| Jun 30, 2025 | 6.98 Mn |
| Mar 31, 2025 | 7.37 Mn |
| Dec 31, 2024 | 5.84 Mn |
| Sep 30, 2024 | 9.23 Mn |
| Jun 30, 2024 | 5.62 Mn |
| Mar 31, 2024 | 2.86 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Dec 31, 2022 | 1.12 Mn |
| Jun 30, 2022 | 2.01 Mn |
| Jun 30, 2021 | 755,049.00 |
| Jun 30, 2020 | 1.07 Mn |